Last 12 months
Inside the activity.
12 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 1 | 3 |
| May 2026 | 0 | 0 |
| Jun 2026 | 11 | 9 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2020 Filed Jul 31, 2020 20:35 UTC |
Albanna Amro A.Director · CHIEF EXECUTIVE OFFICER
|
OtherCommon Stock | 38,055 | $11.25 | $428,118.75 |
DisclosureSEC source: 0001213900-20-019656 · ownership.xml · nonDerivative · entry 1 Albanna Amro A. · CIK 0001424733 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,110 Read SEC document |
| July 24, 2020 Filed Aug 3, 2020 20:27 UTC |
Shabahang ShahrokhDirector · CHIEF INNOVATION OFFICER
|
OtherSeries B Warrant · Derivative | 47,222 | $11.25 Strike: $0.00 | $531,247.50 |
DisclosureSEC source: 0001213900-20-019990 · ownership.xml · derivative · entry 2 Shabahang Shahrokh · CIK 0001816754 · Director · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 47,222 shares Expires 2025-06-29 F2 · ownership.nature: Held beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee. Read SEC document |
| July 24, 2020 Filed Aug 3, 2020 20:27 UTC |
Shabahang ShahrokhDirector · CHIEF INNOVATION OFFICER
|
OtherCommon Stock | 47,222 | $11.25 | $531,247.50 |
DisclosureSEC source: 0001213900-20-019990 · ownership.xml · nonDerivative · entry 1 Shabahang Shahrokh · CIK 0001816754 · Director · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 996,256 F1 · balance_after: 949,034 shares of common stock are owned beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee. Read SEC document |
| July 22, 2020 Filed Feb 12, 2021 16:05 UTC |
Kiaie NamvarDirector
|
OtherSeries B Warrant · Derivative | 1,111 | $11.25 Strike: $0.00 | $12,498.75 |
DisclosureSEC source: 0001213900-21-008961 · ownership.xml · derivative · entry 5 Kiaie Namvar · CIK 0001817639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,111 shares Expires 2025-07-02 Read SEC document |
| July 22, 2020 Filed Feb 12, 2021 16:05 UTC |
Kiaie NamvarDirector
|
OtherCommon Stock | 1,111 | $11.25 | $12,498.75 |
DisclosureSEC source: 0001213900-21-008961 · ownership.xml · nonDerivative · entry 2 Kiaie Namvar · CIK 0001817639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222 Read SEC document |
| July 02, 2020 Filed Feb 12, 2021 16:05 UTC |
Kiaie NamvarDirector
|
PurchaseSeries B Warrant · Derivative | 1,111 | Not disclosed Strike: $11.25 | Not disclosed |
DisclosureSEC source: 0001213900-21-008961 · ownership.xml · derivative · entry 4 Kiaie Namvar · CIK 0001817639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,111 shares Expires 2025-07-02 F1 · price: The reported securities are included within 1,111 Units purchased by the reporting person for $9.00 per Unit. Each Unit consists of (a) one share of common stock, (b) one Series A Warrant to purchase one share of common stock, and (c) one Series B Warrant to purchase one share of common stock. Read SEC document |
| July 02, 2020 Filed Feb 12, 2021 16:05 UTC |
Kiaie NamvarDirector
|
PurchaseSeries A Warrant · Derivative | 1,111 | Not disclosed Strike: $4.50 | Not disclosed |
DisclosureSEC source: 0001213900-21-008961 · ownership.xml · derivative · entry 3 Kiaie Namvar · CIK 0001817639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111 Underlying: Common Stock · 1,111 shares Expires 2025-07-02 F1 · price: The reported securities are included within 1,111 Units purchased by the reporting person for $9.00 per Unit. Each Unit consists of (a) one share of common stock, (b) one Series A Warrant to purchase one share of common stock, and (c) one Series B Warrant to purchase one share of common stock. Read SEC document |
| July 02, 2020 Filed Feb 12, 2021 16:05 UTC |
Kiaie NamvarDirector
|
PurchaseCommon Stock | 1,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-008961 · ownership.xml · nonDerivative · entry 1 Kiaie Namvar · CIK 0001817639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222 F1 · price: The reported securities are included within 1,111 Units purchased by the reporting person for $9.00 per Unit. Each Unit consists of (a) one share of common stock, (b) one Series A Warrant to purchase one share of common stock, and (c) one Series B Warrant to purchase one share of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.